Literature DB >> 27783186

Right ventricular relative wall thickness as a predictor of outcomes and of right ventricular reverse remodeling for patients with pulmonary hypertension.

Hiroyuki Sano1, Hidekazu Tanaka2, Yoshiki Motoji1, Yuko Fukuda1, Yasuhide Mochizuki1, Yutaka Hatani1, Hiroki Matsuzoe1, Keiko Hatazawa1, Hiroyuki Shimoura1, Junichi Ooka1, Keiko Ryo-Koriyama1, Kazuhiko Nakayama1, Kensuke Matsumoto1, Noriaki Emoto1, Ken-Ichi Hirata1.   

Abstract

Mid-term right ventricular (RV) reverse remodeling after treatment in patients with pulmonary hypertension (PH) is associated with long-term outcome as well as baseline RV remodeling. However, baseline factors influencing mid-term RV reverse remodeling after treatment and its prognostic capability remain unclear. We studied 54 PH patients. Mid-term RV remodeling was assessed in terms of the RV area, which was traced planimetrically at the end-systole (RVESA). RV reverse remodeling was defined as a relative decrease in the RVESA of at least 15% at 10.2 ± 9.4 months after treatment. Long-term follow-up was 5 years. Adverse events occurred in ten patients (19%) and mid-term RV reverse remodeling after treatment was observed in 37 (69%). Patients with mid-term RV reverse remodeling had more favorable long-term outcomes than those without (log-rank: p = 0.01). Multivariate logistic regression analysis showed that RV relative wall thickness (RV-RWT), as calculated as RV free-wall thickness/RV basal linear dimension at end-diastole, was an independent predictor of mid-term RV reverse remodeling (OR 1.334; 95% CI, 1.039-1.713; p = 0.03). Moreover, patients with RV-RWT ≥0.21 showed better long-term outcomes than did those without (log-rank p = 0.03), while those with RV-RWT ≥0.21 and mid-term RV reverse remodeling had the best long-term outcomes. Patients with RV-RWT <0.21 and without mid-term RV reverse remodeling, on the other hand, had worse long-term outcomes than other sub-groups. In conclusions, RV-RWT could predict mid-term RV reverse remodeling after treatment in PH patients, and was associated with long-term outcomes. Our finding may have clinical implications for better management of PH patients.

Entities:  

Keywords:  Echocardiography; Pulmonary hypertension; Right ventricular function; Right ventricular reverse remodeling

Mesh:

Substances:

Year:  2016        PMID: 27783186     DOI: 10.1007/s10554-016-1004-z

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  32 in total

1.  Utility of right ventricular free wall speckle-tracking strain for evaluation of right ventricular performance in patients with pulmonary hypertension.

Authors:  Yuko Fukuda; Hidekazu Tanaka; Daisuke Sugiyama; Keiko Ryo; Tetsuari Onishi; Hiroyuki Fukuya; Munenobu Nogami; Yoshiharu Ohno; Noriaki Emoto; Hiroya Kawai; Ken-Ichi Hirata
Journal:  J Am Soc Echocardiogr       Date:  2011-07-19       Impact factor: 5.251

Review 2.  The right ventricle under pressure: evaluating the adaptive and maladaptive changes in the right ventricle in pulmonary arterial hypertension using echocardiography (2013 Grover Conference series).

Authors:  Alexis Harrison; Nathan Hatton; John J Ryan
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

3.  Interdependence of right ventricular systolic function and left ventricular filling and its association with outcome for patients with pulmonary hypertension.

Authors:  Yoshiki Motoji; Hidekazu Tanaka; Yuko Fukuda; Hiroyuki Sano; Keiko Ryo; Junichi Imanishi; Tatsuya Miyoshi; Takuma Sawa; Yasuhide Mochizuki; Kensuke Matsumoto; Noriaki Emoto; Ken-ichi Hirata
Journal:  Int J Cardiovasc Imaging       Date:  2015-01-23       Impact factor: 2.357

4.  Tricuspid annular displacement predicts survival in pulmonary hypertension.

Authors:  Paul R Forfia; Micah R Fisher; Stephen C Mathai; Traci Housten-Harris; Anna R Hemnes; Barry A Borlaug; Elzbieta Chamera; Mary C Corretti; Hunter C Champion; Theodore P Abraham; Reda E Girgis; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2006-08-03       Impact factor: 21.405

5.  Prognostic value of right ventricular longitudinal peak systolic strain in patients with pulmonary hypertension.

Authors:  Marlieke L A Haeck; Roderick W C Scherptong; Nina Ajmone Marsan; Eduard R Holman; Martin J Schalij; Jeroen J Bax; Hubert W Vliegen; Victoria Delgado
Journal:  Circ Cardiovasc Imaging       Date:  2012-08-08       Impact factor: 7.792

6.  Cardiac glutaminolysis: a maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertension.

Authors:  Lin Piao; Yong-Hu Fang; Kishan Parikh; John J Ryan; Peter T Toth; Stephen L Archer
Journal:  J Mol Med (Berl)       Date:  2013-06-21       Impact factor: 4.599

7.  Three-dimensional speckle tracking of the right ventricle: toward optimal quantification of right ventricular dysfunction in pulmonary hypertension.

Authors:  Benjamin C F Smith; Gary Dobson; David Dawson; Athanasios Charalampopoulos; Julia Grapsa; Petros Nihoyannopoulos
Journal:  J Am Coll Cardiol       Date:  2014-07-08       Impact factor: 24.094

8.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

9.  Time course of reversed cardiac remodeling after pulmonary endarterectomy in patients with chronic pulmonary thromboembolism.

Authors:  Misako Iino; Steven Dymarkowski; Lertlak Chaothawee; Marion Delcroix; Jan Bogaert
Journal:  Eur Radiol       Date:  2007-12-20       Impact factor: 5.315

10.  Echocardiographic predictors of mortality in patients with pulmonary hypertension and cardiopulmonary comorbidities.

Authors:  Johannes Steiner; Wen-Chih Wu; Matthew Jankowich; Bradley A Maron; Satish Sharma; Gaurav Choudhary
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

View more
  2 in total

Review 1.  Multimodality Imaging of the Right Ventricle.

Authors:  Christiane M Abouzeid; Tara Shah; Ansh Johri; Jonathan W Weinsaft; Jiwon Kim
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-09-25

2.  Genetic Admixture and Survival in Diverse Populations with Pulmonary Arterial Hypertension.

Authors:  Jason H Karnes; Howard W Wiener; Tae-Hwi Schwantes-An; Balaji Natarajan; Andrew J Sweatt; Abhishek Chaturvedi; Amit Arora; Ken Batai; Vineet Nair; Heidi E Steiner; Jason B Giles; Jeffrey Yu; Maryam Hosseini; Michael W Pauciulo; Katie A Lutz; Anna W Coleman; Jeremy Feldman; Rebecca Vanderpool; Haiyang Tang; Joe G N Garcia; Jason X-J Yuan; Rick Kittles; Vinicio de Jesus Perez; Roham T Zamanian; Franz Rischard; Hemant K Tiwari; William C Nichols; Raymond L Benza; Ankit A Desai
Journal:  Am J Respir Crit Care Med       Date:  2020-06-01       Impact factor: 21.405

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.